Collegium Pharmaceutical Inc (COLL) — Working Capital to Net Assets Ratio
Collegium Pharmaceutical Inc (COLL) has a Working Capital to Net Assets ratio of 58.6% as of September 2025. Working capital of $160.94 Million (current assets of $613.87 Million minus current liabilities of $452.93 Million) is measured against net assets of $274.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Collegium Pharmaceutical Inc net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Collegium Pharmaceutical Inc Working Capital to Net Assets (2013–2024)
This chart shows how Collegium Pharmaceutical Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 58.6%, reflecting working capital of $160.94 Million against net assets of $274.81 Million USD. Check Collegium Pharmaceutical Inc (COLL) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Collegium Pharmaceutical Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Collegium Pharmaceutical Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -11.9% | $-27.25 Million | $228.84 Million | $482.26 Million | $509.51 Million | ▼ -52.7 pp |
| 2023 | 40.8% | $79.69 Million | $195.43 Million | $537.60 Million | $457.92 Million | ▲ +47.8 pp |
| 2022 | -7.1% | $-13.74 Million | $194.84 Million | $419.99 Million | $433.73 Million | ▼ -24.8 pp |
| 2021 | 17.7% | $35.98 Million | $202.93 Million | $315.54 Million | $279.57 Million | ▼ -2.9 pp |
| 2020 | 20.7% | $38.44 Million | $186.03 Million | $277.89 Million | $239.45 Million | ▼ -41.0 pp |
| 2019 | 61.7% | $53.95 Million | $87.43 Million | $255.72 Million | $201.76 Million | ▲ +7.1 pp |
| 2018 | 54.6% | $50.03 Million | $91.58 Million | $237.51 Million | $187.48 Million | ▼ -43.4 pp |
| 2017 | 98.0% | $102.00 Million | $104.08 Million | $133.48 Million | $31.49 Million | ▼ -2.5 pp |
| 2016 | 100.5% | $135.65 Million | $134.91 Million | $158.57 Million | $22.93 Million | ▼ -6.6 pp |
| 2015 | 107.1% | $91.12 Million | $85.07 Million | $96.88 Million | $5.76 Million | ▲ +58.7 pp |
| 2014 | 48.4% | $-5.92 Million | $-12.24 Million | $4.50 Million | $10.42 Million | ▼ -52.7 pp |
| 2013 | 101.1% | $5.64 Million | $5.58 Million | $8.26 Million | $2.62 Million | — |